In patients with elevated triglyceride levels despite use of statins, risk of ischaemic events, including cardiovascular (CV) death, was reduced by 25% with icosapent ethyl (IPE) 2 g twice daily compared to placebo.
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
